Protein Production and Purification for USAMRICD
ID: PANMRA-24-P-0000001928Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH (AJ11)

Original Source

https://sam.gov/opp/6e6fa2b024c7402599962a9c5a3aa45b/view
Timeline
    Description

    Presolicitation DEPT OF DEFENSE (DEFENSE HEALTH AGENCY) is planning to procure Protein Production and Purification services for USAMRICD. This service is required to be self-sufficient in protein production and sustain research operations at USAMRICD. The service involves generating highly purified recombinant human acetylcholinesterase enzyme for use in research to measure the protein's function in critical in vitro biochemical activity assays. The enzyme must meet specific requirements, including maintaining enzymatic activity, being expressed in a system that preserves post-translational modification pattern, and being available at >90% purity. The enzyme will be used in research efforts that require the measurement of hydrolytic activity using standard biochemical assaying techniques. The procurement of this service is critical for the evaluation of novel drugs and is expected to continue for at least three years. Interested parties can submit their capability by email to Mr. Kenneth Grenier, Contract Specialist, by 18 February 2024 at 12:00 PM (Noon) Eastern Time.

    Point(s) of Contact
    Ken Grenier
    kenneth.e.grenier2.civ@health.mil
    Erin Maddox
    erin.j.maddox.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Protein Production and Purification for USAMRICD
    Currently viewing
    Presolicitation
    Similar Opportunities
    Cryopreserved Platelets (CPP) for US FDA Licensure
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking input from qualified entities for the development of Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP) aimed at enhancing the shelf life of platelet products for military use. This initiative is part of the U.S. Combat Casualty Care Research Program and focuses on creating a biologic product that can be stored for up to two years, significantly improving upon the current five-day storage limit for liquid stored platelets. The project is critical for ensuring the readiness and quality of life for active-duty personnel, with a low-rate initial production goal of 1,500 units anticipated over a 20-month performance period. Interested parties are encouraged to submit a white paper detailing their capabilities and relevant experience by January 20, 2025, and can contact Peter Mitchell at peter.d.mitchell8.civ@health.mil for further information.
    SOURCES SOUGHT: Mass Spectrometry Reagents
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking qualified small business sources for the procurement of specialized Mass Spectrometry Reagents aimed at advancing research on Alzheimer’s Disease and related dementias. The objective is to establish a national resource of isogenic induced pluripotent stem cell (iPSC) lines to study genetic mutations associated with these diseases, thereby accelerating mechanistic discovery. This procurement is critical for enhancing the understanding of Alzheimer’s disease mechanisms and includes specific requirements for HPLC columns and related supplies, with the first delivery expected by July 7, 2025, and additional options extending to July 2027. Interested parties should submit their capability statements to Rashiid Cummins at Rashiid.Cummins@nih.gov by January 21, 2025, at 3:00 PM Eastern Time.
    NUcleic acid Linked Immuno-Sandwich Assay Reagents
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NUcleic acid Linked Immuno-Sandwich Assay Reagents, aimed at enhancing biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The acquisition includes the Alamar NULISAseq Inflammation Panel, with a requirement for 30 units that must demonstrate high sensitivity in analyzing over 250 proteins from minimal sample volumes, ensuring compatibility with the ARGO proteomics platform. This procurement is critical for advancing research capabilities in the detection of biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Interested vendors must submit their quotations by January 22, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nida.nih.gov, and must comply with all specified federal regulations and provisions outlined in the solicitation.
    ANTIBODY REAGENT KITS
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to procure antibody reagent kits from Abcam, Inc. for a technology development project aimed at validating results from mass cytometry panels used to study the human immune system. These antibody kits are crucial for phenotyping the immunome, which is essential for understanding both normal and pathogenic immune responses in various diseases. Interested vendors capable of providing comparable services are invited to submit a capabilities statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 9:00 AM EST on January 21, 2025. For further inquiries, vendors may contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D Weidow at weidowjd@niaid.nih.gov.
    Sources Sought for Benchtop Parallel Bioreactor System
    Dept Of Defense
    The Department of Defense, specifically the Army Research Laboratory, is seeking sources for a Benchtop Parallel Bioreactor System to enhance research operations at the University of Texas at Austin. The procurement aims to acquire a system capable of operating up to four vessels with specific environmental control features, supporting both bacteria and yeast batch processing, and requiring advanced software functionalities for process management and reporting. This initiative is crucial for advancing research capabilities in bioreactor technology, ensuring compliance with rigorous operational standards. Interested vendors, particularly small businesses, are encouraged to respond by January 21, 2025, with inquiries directed to Contract Specialist Stency Steephan at stency.f.steephan.civ@army.mil or by phone at 520-672-9594.
    Note of Intent to Award Sole Source
    Dept Of Defense
    The Department of Defense, through the United States Army Medical Research Acquisitions Activity (USAMRAA), intends to modify an existing contract related to the CryoPreserved Platelets (CPP) project. This modification aims to increase the cost ceiling to accommodate the need for additional subjects in clinical trials, which is critical for advancing to Phase 3 and obtaining FDA licensure for CPP. The contract modification will cover various activities, including the recruitment of up to 400 more subjects, increased consultant and travel expenses, material costs, regulatory expenses, and site activations, with no other FDA-licensed manufacturers for CPP identified in the U.S. Interested suppliers are encouraged to respond in writing within 15 days of this notice, and inquiries can be directed to Peter Mitchell at peter.d.mitchell8.civ@health.mil.
    Sources Sought Notice for Chemiluminescent immunoassay (CLIA) kits compatible with the government’s current CLIA instrumentation for the Brooke Army Medical Center (BAMC).
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources to provide Chemiluminescent immunoassay (CLIA) kits compatible with the existing CLIA instrumentation at the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The procurement aims to secure FDA-approved assay kits that meet specific testing requirements, including rapid turnaround times and comprehensive training for laboratory staff. This initiative is crucial for maintaining efficient laboratory services and public health monitoring, as it supports a range of immunological tests essential for patient care. Interested vendors are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil by the specified deadline, with a base performance period anticipated from October 1, 2025, to September 30, 2030.
    Public Health Industrial Base Capabilities and Capacities: Anti-Microbials
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking industry partners to provide information on domestic production capabilities related to anti-microbials as part of the Defense Production Act Title III Program. The objective is to gather data that will enhance the understanding of the Public Health Industrial Base (PHIB) and identify gaps in the marketplace that can be addressed through Title III authorities, which incentivize domestic production. This initiative is crucial for ensuring a reliable supply of essential health resources necessary for national defense and public health, particularly in light of the recent Presidential Determination 2024-03. Interested parties are invited to submit their responses by January 22, 2025, at 10 AM ET, to Chris Newell at IBMSC-Submissions@hhs.gov or Christopher.Newell@hhs.gov.
    Biotin Molecules
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking suppliers for various biotin molecules through a combined synopsis/solicitation. The procurement includes specific biotin products such as B-100-B a-Bungarotoxin-Biotin, STC-460-B Chlorotoxin-Biotin, STS-400-B Stichodactyla Toxin-Biotin, and STC-666-B Conantokin G-Biotin, each in 50ug quantities. These biotin molecules are essential for various analytical and laboratory applications, contributing to research and development in biochemical fields. Interested vendors can reach out to Carl Lundell at carl.lundell@westpoint.edu or call 845.938.8298 for further details regarding the procurement process.
    Microbiology Lab CPRR - Keesler AFB, MS
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the procurement of microbiology laboratory equipment at Keesler Air Force Base in Mississippi. The requirement includes one automated microbial identification system and one automated microbial detection system, along with all necessary reagents, equipment maintenance, and training services. This procurement is crucial for enhancing the laboratory's capabilities in microbial testing, which is vital for patient care and public health safety. Interested vendors must submit their proposals by January 24, 2025, and can direct inquiries to Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil for further information.